title: [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
abstract: A seroepidemiological study, including a interview-questionnaire, was carried out in a representative sample of children from Salamanca (Spain) between the ages of 15 months and 7 years. The objective of this study was to know the vaccination level and the immune status against measles, mumps and rubella (MMR). The vaccination level with MMR-vaccine was 70%. The antibody prevalence was 84% against measles, 85.3%, against mumps and 76.7% against rubella. The number of children with antibodies against all three diseases was 66%. Nineteen percent of the children vaccinated with MMR-vaccine were susceptible to one or more of the three diseases. The administration of a second dose of MMR-vaccine may be considered necessary.
authors.affiliation: Departamento de Medicina Preventiva y Salud Pública, Hospital Clínico Universitario, Facultad de Medicina, Salamanca.
authors.forename: M C
authors.initials: MC
authors.lastname: Sáenz González
authors.forename: J C
authors.initials: JC
authors.lastname: Núñez Mateos
authors.forename: N
authors.initials: N
authors.lastname: Rodrigo Sánchez
authors.forename: A M
authors.initials: AM
authors.lastname: Martín Sánchez
mesh_terms: D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008457:Measles / Q000453:epidemiology* / Q000276:immunology; D008458:Measles Vaccine / Q000008:administration & dosage; D009107:Mumps / Q000453:epidemiology* / Q000276:immunology; D009108:Mumps Vaccine / Q000008:administration & dosage; D012409:Rubella / Q000453:epidemiology* / Q000276:immunology; D012411:Rubella Vaccine / Q000008:administration & dosage; D013030:Spain / Q000453:epidemiology; D014611:Vaccination
chemical_list: D008458:Measles Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine
vernacular_title: Estudio seroepidemiológico del sarampión, rubeola y parotiditis en la población infantil salmantina.